NCT02494375

Brief Summary

The primary goal of the study is to determine whether insufficient sleep is associated with poor glycemic control in type 1 diabetic children. Secondary goals aim to determine whether salivary amylase could be an easily accessible and non-invasive biomarker of sleep loss and somnolence, and whether insufficient sleep is linked to body composition. Sleep characteristics, glycemic control, salivary amylase and body composition will be assessed 3 times, at 3-4 months intervals, in 82 type 1 diabetic children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2015

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 10, 2015

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

October 5, 2020

Status Verified

October 1, 2020

Enrollment Period

7.4 years

First QC Date

July 3, 2015

Last Update Submit

October 1, 2020

Conditions

Keywords

Sleepglycemic controltype 1 diabetesamylasebody compositionleanoverweightobese

Outcome Measures

Primary Outcomes (1)

  • Association between HbA1c and sleep characteristics

    Month 3, Month 6 and Month 9

Secondary Outcomes (3)

  • Glucose levels

    Month 3, Month 6 and Month 9

  • Daily salivary amylase variation (Enzyme Activity)

    Month 3, Month 6 and Month 9

  • Body composition (BMI fat and lean mass percentage)

    Month 3, Month 6 and Month 9

Study Arms (1)

Sleep and glucose assessement.

EXPERIMENTAL
Other: Sleep and glucose assessments

Interventions

Sleep characteristics, glycemic control, salivary amylase and body composition will be assessed 3 times, at 3-4 months intervals

Sleep and glucose assessement.

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- Female and male type 1 diabetic children and adolescents who are followed at the Woman, Mother and Child's Hospital (Hôpital Femme Mère Enfant : HFME) of Bron, France.

You may not qualify if:

  • Refusal of consent of the parents or the child or the adolescent
  • Pregnancy
  • Concomitant pathology that severly impacts sleep
  • Implanted electrical stimulation device
  • Diagnosis of type 1 diabetes \<1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Lyon, 69000, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1OverweightObesity

Interventions

Sleep

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2015

First Posted

July 10, 2015

Study Start

June 28, 2015

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

October 5, 2020

Record last verified: 2020-10

Locations